IPC Classification

All sections
A - Human necessities
A61K - Preparations for medical, dental or toiletry purposes

A61K 6/00	Preparations for dentistry
A61K 6/02	Use of preparations for artificial teeth, for filling or for capping teeth
A61K 6/04	Use of metals or alloys
A61K 6/05	Amalgams
A61K 6/06	Use of inorganic cements
A61K 6/08	Use of natural or synthetic resins
A61K 6/09	Polyurethanes
A61K 6/10	Compositions for taking dental impressions
A61K 6/15	Compositions characterised by their physical properties
A61K 6/16	Refractive index
A61K 6/17	Particle size
A61K 6/18	Compositions characterised by their physical properties causing dental retraction, e.g. compositions for widening the sulcus for making dental impressions or removing teeth
A61K 6/19	Self-expanding, e.g. for filling teeth
A61K 6/20	Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
A61K 6/25	Compositions for detecting or measuring, e.g. of irregularities on natural or artificial teeth
A61K 6/027	Use of non-metallic elements or compounds thereof, e.g. carbon
A61K 6/30	Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
A61K 6/033	Phosphorus compounds, e.g. apatite
A61K 6/35	Preparations for stabilising dentures in the mouth
A61K 6/40	Primers
A61K 6/50	Preparations specially adapted for dental root treatment
A61K 6/52	Cleaning; Disinfecting
A61K 6/54	Filling; Sealing
A61K 6/56	Apical treatment
A61K 6/58	Preparations specially adapted for dental root treatment specially adapted for dental implants
A61K 6/60	Preparations for dentistry comprising organic or organo-metallic additives
A61K 6/61	Cationic, anionic or redox initiators
A61K 6/62	Photochemical radical initiators
A61K 6/64	Thermal radical initiators
A61K 6/65	Dyes
A61K 6/66	Photochromic dyes
A61K 6/68	Thermochromic dyes
A61K 6/69	Medicaments
A61K 6/70	Preparations for dentistry comprising inorganic additives
A61K 6/71	Fillers
A61K 6/72	Fillers comprising nitrogen-containing compounds
A61K 6/73	Fillers comprising sulfur-containing compounds
A61K 6/74	Fillers comprising phosphorus-containing compounds
A61K 6/75	Apatite
A61K 6/76	Fillers comprising silicon-containing compounds
A61K 6/77	Glass
A61K 6/78	Pigments
A61K 6/79	Initiators
A61K 6/80	Preparations for artificial teeth, for filling teeth or for capping teeth
A61K 6/82	Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising hafnium oxide
A61K 6/083	Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
A61K 6/84	Preparations for artificial teeth, for filling teeth or for capping teeth comprising metals or alloys
A61K 6/86	Al-cements
A61K 6/087	Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
A61K 6/88	Chromium oxide
A61K 6/90	Compositions for taking dental impressions
A61K 6/093	Polyorganosilicon compounds
A61K 6/097	Polysaccharides
A61K 6/802	Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics
A61K 6/804	Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising manganese oxide
A61K 6/807	Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising magnesium oxide
A61K 6/809	Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising beryllium oxide
A61K 6/811	Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising chromium oxide
A61K 6/813	Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising iron oxide
A61K 6/816	Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising titanium oxide
A61K 6/818	Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising zirconium oxide
A61K 6/822	Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising rare earth metal oxides
A61K 6/824	Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising transition metal oxides
A61K 6/827	Leucite
A61K 6/829	Preparations for artificial teeth, for filling teeth or for capping teeth comprising cermet composites
A61K 6/831	Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
A61K 6/833	Glass-ceramic composites
A61K 6/836	Glass
A61K 6/838	Phosphorus compounds, e.g. apatite
A61K 6/842	Rare earth metals
A61K 6/844	Noble metals
A61K 6/847	Amalgams
A61K 6/849	Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
A61K 6/851	Portland cements
A61K 6/853	Silicates
A61K 6/856	Pozzolans
A61K 6/858	Calcium sulfates, e.g, gypsum
A61K 6/862	Ca-Al-sulfate-cements
A61K 6/864	Phosphate cements
A61K 6/867	Ammonium cements
A61K 6/869	Zeolites
A61K 6/871	Quartz; SiO2
A61K 6/873	Carbonates
A61K 6/876	Calcium oxide
A61K 6/878	Zirconium oxide
A61K 6/882	Carbides
A61K 6/884	Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
A61K 6/887	Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
A61K 6/889	Polycarboxylate cements; Glass ionomer cements
A61K 6/891	Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
A61K 6/893	Polyurethanes
A61K 6/896	Polyorganosilicon compounds
A61K 6/898	Polysaccharides
A61K 8/00	Cosmetics or similar toiletry preparations
A61K 8/02	Cosmetics or similar toiletry preparations characterised by special physical form
A61K 8/03	Liquid compositions with two or more distinct layers
A61K 8/04	Dispersions; Emulsions
A61K 8/06	Emulsions
A61K 8/11	Encapsulated compositions
A61K 8/14	Liposomes
A61K 8/18	Cosmetics or similar toiletry preparations characterised by the composition
A61K 8/19	Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
A61K 8/20	Halogens; Compounds thereof
A61K 8/21	Fluorides; Derivatives thereof
A61K 8/22	Peroxides; Oxygen; Ozone
A61K 8/23	Sulfur; Selenium; Tellurium; Compounds thereof
A61K 8/24	Phosphorus; Compounds thereof
A61K 8/25	Silicon; Compounds thereof
A61K 8/26	Aluminium; Compounds thereof
A61K 8/27	Zinc; Compounds thereof
A61K 8/28	Zirconium; Compounds thereof
A61K 8/29	Titanium; Compounds thereof
A61K 8/30	Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
A61K 8/31	Hydrocarbons
A61K 8/33	Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
A61K 8/34	Alcohols
A61K 8/35	Ketones, e.g. quinones, benzophenone
A61K 8/36	Carboxylic acids; Salts or anhydrides thereof
A61K 8/37	Esters of carboxylic acids
A61K 8/38	Percompounds, e.g. peracids
A61K 8/39	Derivatives containing from 2 to 10 oxyalkylene groups
A61K 8/40	Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
A61K 8/41	Amines
A61K 8/42	Amides
A61K 8/43	Guanidines
A61K 8/44	Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts, esters or N-acylated derivatives thereof
A61K 8/45	Derivatives containing from 2 to 10 oxyalkylene groups
A61K 8/46	Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
A61K 8/49	Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
A61K 8/55	Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing phosphorus
A61K 8/58	Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
A61K 8/60	Sugars; Derivatives thereof
A61K 8/63	Steroids; Derivatives thereof
A61K 8/64	Proteins; Peptides; Derivatives or degradation products thereof
A61K 8/65	Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
A61K 8/66	Enzymes
A61K 8/67	Vitamins
A61K 8/68	Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
A61K 8/69	Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
A61K 8/70	Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
A61K 8/72	Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
A61K 8/73	Polysaccharides
A61K 8/81	Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
A61K 8/84	Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions other than those involving only carbon-to-carbon unsaturated bonds
A61K 8/85	Polyesters
A61K 8/86	Polyethers
A61K 8/87	Polyurethanes
A61K 8/88	Polyamides
A61K 8/89	Polysiloxanes
A61K 8/90	Block copolymers
A61K 8/91	Graft copolymers
A61K 8/92	Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products
A61K 8/96	Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution
A61K 8/97	Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from derivatives thereof
A61K 8/98	Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution of animal origin
A61K 8/99	Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
A61K 8/362	Polycarboxylic acids
A61K 8/365	Hydroxycarboxylic acids; Ketocarboxylic acids
A61K 8/368	Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
A61K 8/891	Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
A61K 8/892	Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a hydroxy group, e.g. dimethiconol
A61K 8/893	Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by an alkoxy or aryloxy group, e.g. behenoxy dimethicone or stearoxy dimethicone
A61K 8/894	Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
A61K 8/895	Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
A61K 8/896	Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
A61K 8/897	Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing halogen, e.g. fluorosilicones
A61K 8/898	Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
A61K 8/899	Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing sulfur, e.g. sodium PG-propyldimethicone thiosulfate copolyol
A61K 8/9706	Algae
A61K 8/9711	Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
A61K 8/9717	Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
A61K 8/9722	Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
A61K 8/9728	Fungi, e.g. yeasts
A61K 8/9733	Lichens
A61K 8/9739	Bryophyta [mosses]
A61K 8/9741	Pteridophyta [ferns]
A61K 8/9749	Filicopsida or Pteridopsida
A61K 8/9755	Gymnosperms [Coniferophyta]
A61K 8/9761	Cupressaceae [Cypress family], e.g. juniper or cypress
A61K 8/9767	Pinaceae [Pine family], e.g. pine or cedar
A61K 8/9771	Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
A61K 8/9778	Gnetophyta, e.g. Ephedraceae [Mormon-tea family]
A61K 8/9783	Angiosperms [Magnoliophyta]
A61K 8/9789	Magnoliopsida [dicotyledons]
A61K 8/9794	Liliopsida [monocotyledons]
A61K 9/00	Medicinal preparations characterised by special physical form
A61K 9/02	Suppositories; Bougies; Bases for suppositories or bougies
A61K 9/06	Ointments; Bases therefor
A61K 9/08	Solutions
A61K 9/10	Dispersions; Emulsions
A61K 9/12	Aerosols; Foams
A61K 9/14	Particulate form, e.g. powders
A61K 9/16	Agglomerates; Granulates; Microbeadlets
A61K 9/18	Adsorbates
A61K 9/19	Particulate form, e.g. powders lyophilised
A61K 9/20	Pills, lozenges or tablets
A61K 9/22	Sustained or differential release type
A61K 9/24	Layered or laminated unitary dosage forms
A61K 9/26	Discrete particles in supporting matrix
A61K 9/28	Dragees; Coated pills or tablets
A61K 9/30	Organic coatings
A61K 9/32	Organic coatings containing solid synthetic polymers
A61K 9/34	Organic coatings containing natural gums or resins
A61K 9/36	Organic coatings containing carbohydrates or derivatives thereof
A61K 9/38	Organic coatings containing proteins or derivatives thereof
A61K 9/40	Gelatin containing
A61K 9/42	Organic coatings containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof, e.g. chocolate
A61K 9/44	Pills, lozenges or tablets printed, embossed, grooved, or perforated
A61K 9/46	Pills, lozenges or tablets effervescent
A61K 9/48	Preparations in capsules, e.g. of gelatin, of chocolate
A61K 9/50	Microcapsules
A61K 9/51	Nanocapsules
A61K 9/52	Sustained or differential release type
A61K 9/54	Sustained or differential release type containing discrete particles with coatings of different thicknesses or different materials
A61K 9/56	Organic coatings
A61K 9/58	Organic coatings containing solid synthetic polymers
A61K 9/60	Organic coatings containing natural gums or resins
A61K 9/62	Organic coatings containing carbohydrates or derivatives thereof
A61K 9/64	Organic coatings containing proteins or derivatives thereof
A61K 9/66	Sustained or differential release type containing emulsions, dispersions or solutions
A61K 9/68	Medicinal preparations characterised by special physical form chewing gum type
A61K 9/70	Web, sheet or filament bases
A61K 9/72	Medicinal preparations characterised by special physical form for smoking or inhaling
A61K 9/107	Emulsions
A61K 9/113	Multiple emulsions, e.g. oil-in-water-in-oil
A61K 9/127	Liposomes
A61K 9/133	Unilamellar vesicles
A61K 31/00	Medicinal preparations containing organic active ingredients
A61K 31/01	Hydrocarbons
A61K 31/02	Halogenated hydrocarbons
A61K 31/03	Halogenated hydrocarbons carbocyclic aromatic
A61K 31/04	Nitro compounds
A61K 31/05	Phenols
A61K 31/06	Phenols the aromatic ring being substituted by nitro groups
A61K 31/07	Retinol compounds, e.g. vitamin A
A61K 31/08	Ethers or acetals acyclic, e.g. paraformaldehyde
A61K 31/09	Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
A61K 31/10	Sulfides; Sulfoxides; Sulfones
A61K 31/11	Aldehydes
A61K 31/12	Ketones
A61K 31/13	Amines, e.g. amantadine
A61K 31/14	Quaternary ammonium compounds, e.g. edrophonium, choline
A61K 31/15	Oximes (C=N—O—); Hydrazines (N—N); Hydrazones (N—N=)
A61K 31/16	Amides, e.g. hydroxamic acids
A61K 31/17	Amides, e.g. hydroxamic acids having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine
A61K 31/18	Sulfonamides
A61K 31/19	Carboxylic acids, e.g. valproic acid
A61K 31/20	Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
A61K 31/21	Esters, e.g. nitroglycerine, selenocyanates
A61K 31/22	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
A61K 31/23	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
A61K 31/24	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
A61K 31/25	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
A61K 31/26	Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
A61K 31/27	Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, e.g. meprobamate, carbachol, neostigmine
A61K 31/28	Compounds containing heavy metals
A61K 31/29	Antimony or bismuth compounds
A61K 31/30	Copper compounds
A61K 31/31	Mercury compounds containing nitrogen
A61K 31/32	Tin compounds
A61K 31/33	Heterocyclic compounds
A61K 31/34	Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
A61K 31/35	Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
A61K 31/36	Compounds containing methylenedioxyphenyl groups, e.g. sesamin
A61K 31/37	Coumarins, e.g. psoralen
A61K 31/38	Heterocyclic compounds having sulfur as a ring hetero atom
A61K 31/39	Heterocyclic compounds having sulfur as a ring hetero atom having oxygen atoms in the same ring
A61K 31/40	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A61K 31/41	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
A61K 31/42	Oxazoles
A61K 31/43	Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula , e.g. penicillins, penems
A61K 31/44	Non-condensed pyridines; Hydrogenated derivatives thereof
A61K 31/45	Non-condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
A61K 31/46	8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
A61K 31/47	Quinolines; Isoquinolines
A61K 31/48	Ergoline derivatives, e.g. lysergic acid, ergotamine
A61K 31/49	Cinchonan derivatives, e.g. quinine
A61K 31/50	Pyridazines; Hydrogenated pyridazines
A61K 31/51	Thiamines, e.g. vitamin B1
A61K 31/52	Purines, e.g. adenine
A61K 31/53	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
A61K 31/54	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame
A61K 31/55	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
A61K 31/56	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
A61K 31/57	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
A61K 31/58	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
A61K 31/59	Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems
A61K 31/60	Salicylic acid; Derivatives thereof
A61K 31/63	Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide
A61K 31/64	Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
A61K 31/65	Tetracyclines
A61K 31/66	Phosphorus compounds
A61K 31/67	Phosphorus compounds having sulfur as a ring hetero atom
A61K 31/69	Boron compounds
A61K 31/70	Carbohydrates; Sugars; Derivatives thereof
A61K 31/74	Synthetic polymeric materials
A61K 31/75	Polymers of hydrocarbons of ethene
A61K 31/76	Polymers containing halogen of vinyl chloride
A61K 31/77	Polymers containing oxygen of oxiranes
A61K 31/78	Polymers containing oxygen of acrylic acid or derivatives thereof
A61K 31/79	Polymers of vinyl pyrrolidone
A61K 31/80	Polymers containing hetero atoms not provided for in groups
A61K 31/085	Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
A61K 31/095	Sulfur, selenium or tellurium compounds, e.g. thiols
A61K 31/105	Persulfides
A61K 31/115	Formaldehyde
A61K 31/121	Ketones acyclic
A61K 31/122	Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/125	Camphor; Nuclear substituted derivatives thereof
A61K 31/131	Amines, e.g. amantadine acyclic
A61K 31/132	Amines, e.g. amantadine having two or more amino groups, e.g. spermidine, putrescine
A61K 31/133	Amines, e.g. amantadine having hydroxy groups, e.g. sphingosine
A61K 31/135	Amines, e.g. amantadine having aromatic rings, e.g. methadone
A61K 31/136	Amines, e.g. amantadine having aromatic rings, e.g. methadone having the amino group directly attached to the aromatic ring, e.g. benzeneamine
A61K 31/137	Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
A61K 31/138	Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
A61K 31/145	Amines, e.g. amantadine having sulfur atoms, e.g. thiurams (N—C(S)—S—C(S)—N or N—C(S)—S—S—C(S)—N); Sulfinylamines (—N=SO); Sulfonylamines (—N=SO2)
A61K 31/155	Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (HN=C(OH)NH2), isothiourea (HN=C(SH)—NH2)
A61K 31/164	Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
A61K 31/165	Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
A61K 31/166	Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
A61K 31/167	Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
A61K 31/175	Amides, e.g. hydroxamic acids having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine having the group , N—C(O)—N=N— or , e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
A61K 31/185	Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
A61K 31/191	Acyclic acids having two or more hydroxy groups, e.g. gluconic acid
A61K 31/192	Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
A61K 31/194	Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
A61K 31/195	Carboxylic acids, e.g. valproic acid having an amino group
A61K 31/196	Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
A61K 31/197	Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid (GABA), beta-alanine, epsilon-aminocaproic acid, pantothenic acid
A61K 31/198	Alpha-amino acids, e.g. alanine, edetic acid (EDTA)
A61K 31/201	Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having one or two double bonds, e.g. oleic or linoleic acid
A61K 31/202	Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
A61K 31/203	Retinoic acids
A61K 31/205	Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
A61K 31/215	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
A61K 31/216	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
A61K 31/221	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
A61K 31/222	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
A61K 31/223	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-amino acids
A61K 31/225	Polycarboxylic acids
A61K 31/231	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
A61K 31/232	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
A61K 31/235	Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
A61K 31/245	Amino benzoic acid types, e.g. procaine, novocaine
A61K 31/255	Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
A61K 31/265	Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
A61K 31/275	Nitriles; Isonitriles
A61K 31/277	Nitriles; Isonitriles having a ring, e.g. verapamil
A61K 31/282	Platinum compounds
A61K 31/285	Arsenic compounds
A61K 31/295	Iron group metal compounds
A61K 31/305	Mercury compounds
A61K 31/315	Zinc compounds
A61K 31/325	Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
A61K 31/327	Peroxy compounds, e.g. hydroperoxides, peroxides, peroxy acids
A61K 31/335	Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
A61K 31/336	Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
A61K 31/337	Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
A61K 31/341	Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
A61K 31/343	Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
A61K 31/345	Nitrofurans
A61K 31/351	Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
A61K 31/352	Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/353	3,4-Dihydrobenzopyrans, e.g. chroman, catechin
A61K 31/355	Tocopherols, e.g. vitamin E
A61K 31/357	Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
A61K 31/365	Lactones
A61K 31/366	Lactones having six-membered rings, e.g. delta-lactones
A61K 31/375	Ascorbic acid, i.e. vitamin C; Salts thereof
A61K 31/381	Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
A61K 31/382	Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
A61K 31/385	Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
A61K 31/395	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K 31/396	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having three-membered rings, e.g. aziridine
A61K 31/397	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
A61K 31/401	Proline; Derivatives thereof, e.g. captopril
A61K 31/402	1-aryl-substituted, e.g. piretanide
A61K 31/403	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
A61K 31/404	Indoles, e.g. pindolol
A61K 31/405	Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
A61K 31/407	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine
A61K 31/409	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
A61K 31/415	1,2-Diazoles
A61K 31/416	1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
A61K 31/417	Imidazole-alkylamines, e.g. histamine, phentolamine
A61K 31/421	1,3-Oxazoles, e.g. pemoline, trimethadione
A61K 31/422	Oxazoles not condensed and containing further heterocyclic rings
A61K 31/423	Oxazoles condensed with carbocyclic rings
A61K 31/424	Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
A61K 31/425	Thiazoles
A61K 31/426	1,3-Thiazoles
A61K 31/427	Thiazoles not condensed and containing further heterocyclic rings
A61K 31/428	Thiazoles condensed with carbocyclic rings
A61K 31/429	Thiazoles condensed with heterocyclic ring systems
A61K 31/431	Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula , e.g. penicillins, penems containing further heterocyclic ring systems, e.g. ticarcillin, azlocillin, oxacillin
A61K 31/433	Thiadiazoles
A61K 31/435	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
A61K 31/436	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
A61K 31/437	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A61K 31/438	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring being spiro-condensed with carbocyclic or heterocyclic ring systems
A61K 31/439	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
A61K 31/443	Non-condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
A61K 31/444	Non-condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone
A61K 31/445	Non-condensed piperidines, e.g. piperocaine
A61K 31/451	Non-condensed piperidines, e.g. piperocaine having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
A61K 31/452	Piperidinium derivatives
A61K 31/453	Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
A61K 31/454	Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
A61K 31/455	Nicotinic acid, i.e. niacin; Derivatives thereof, e.g. esters, amides
A61K 31/465	Nicotine; Derivatives thereof
A61K 31/472	Non-condensed isoquinolines, e.g. papaverine
A61K 31/473	Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
A61K 31/475	Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
A61K 31/485	Morphinan derivatives, e.g. morphine, codeine
A61K 31/495	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
A61K 31/496	Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
A61K 31/497	Non-condensed pyrazines containing further heterocyclic rings
A61K 31/498	Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
A61K 31/499	Spiro-condensed pyrazines or piperazines
A61K 31/501	Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
A61K 31/502	Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
A61K 31/503	Pyridazines; Hydrogenated pyridazines spiro-condensed
A61K 31/504	Pyridazines; Hydrogenated pyridazines forming part of bridged ring systems
A61K 31/505	Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
A61K 31/506	Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
A61K 31/513	Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
A61K 31/515	Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
A61K 31/517	Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
A61K 31/519	Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
A61K 31/522	Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
A61K 31/525	Isoalloxazines, e.g. riboflavins, vitamin B2
A61K 31/527	Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim spiro-condensed
A61K 31/529	Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim forming part of bridged ring systems
A61K 31/535	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
A61K 31/536	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
A61K 31/537	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
A61K 31/538	1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
A61K 31/539	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more oxygen atoms in the same ring, e.g dioxazines
A61K 31/541	Non-condensed thiazines containing further heterocyclic rings
A61K 31/542	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
A61K 31/545	Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine
A61K 31/546	Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine containing further heterocyclic rings, e.g. cephalothin
A61K 31/547	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame spiro-condensed or forming part of bridged ring systems
A61K 31/548	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame having two or more sulfur atoms in the same ring
A61K 31/549	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
A61K 31/551	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep
A61K 31/553	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
A61K 31/554	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
A61K 31/555	Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
A61K 31/557	Eicosanoids, e.g. leukotrienes
A61K 31/558	Eicosanoids, e.g. leukotrienes having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
A61K 31/559	Eicosanoids, e.g. leukotrienes having heterocyclic rings containing hetero atoms other than oxygen
A61K 31/565	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
A61K 31/566	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol having an oxo group in position 17, e.g. oestrone
A61K 31/567	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
A61K 31/568	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61K 31/569	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone substituted in position 17 alpha, e.g. ethisterone
A61K 31/573	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
A61K 31/575	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
A61K 31/585	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
A61K 31/592	9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D2
A61K 31/593	9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
A61K 31/603	Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
A61K 31/606	Salicylic acid; Derivatives thereof having amino groups
A61K 31/609	Amides, e.g. salicylamide
A61K 31/612	Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
A61K 31/616	Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
A61K 31/618	Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
A61K 31/621	Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
A61K 31/625	Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicyloylmorpholine
A61K 31/635	Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide having a heterocyclic ring, e.g. sulfadiazine
A61K 31/655	Azo (—N=N—), diazo (=N2), azoxy (N—O—N or N(=O)—N), azido (—N3) or diazoamino (—N=N—N) compounds
A61K 31/661	Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion
A61K 31/662	Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
A61K 31/663	Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
A61K 31/664	Amides of phosphorus acids
A61K 31/665	Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
A61K 31/675	Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
A61K 31/683	Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
A61K 31/685	Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
A61K 31/688	Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
A61K 31/695	Silicon compounds
A61K 31/702	Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
A61K 31/704	Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
A61K 31/706	Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
A61K 31/708	Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
A61K 31/711	Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
A61K 31/712	Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
A61K 31/713	Double-stranded nucleic acids or oligonucleotides
A61K 31/714	Cobalamins, e.g. cyanocobalamin, vitamin B12
A61K 31/715	Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
A61K 31/716	Glucans
A61K 31/717	Celluloses
A61K 31/718	Starch or degraded starch, e.g. amylose, amylopectin
A61K 31/719	Pullulans
A61K 31/721	Dextrans
A61K 31/722	Chitin; Chitosan
A61K 31/723	Xanthans
A61K 31/724	Cyclodextrins
A61K 31/726	Glycosaminoglycans, i.e. mucopolysaccharides
A61K 31/727	Heparin; Heparan
A61K 31/728	Hyaluronic acid
A61K 31/729	Agar; Agarose; Agaropectin
A61K 31/731	Carrageenans
A61K 31/732	Pectin
A61K 31/733	Fructosans, e.g. inulin
A61K 31/734	Alginic acid
A61K 31/736	Glucomannans or galactomannans, e.g locust bean gum, guar gum
A61K 31/737	Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
A61K 31/738	Cross-linked polysaccharides
A61K 31/739	Lipopolysaccharides
A61K 31/745	Polymers of hydrocarbons
A61K 31/755	Polymers containing halogen
A61K 31/765	Polymers containing oxygen
A61K 31/775	Phenolic resins
A61K 31/785	Polymers containing nitrogen
A61K 31/787	Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
A61K 31/795	Polymers containing sulfur
A61K 31/4015	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
A61K 31/4025	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
A61K 31/4035	Isoindoles, e.g. phthalimide
A61K 31/4045	Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
A61K 31/4152	1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
A61K 31/4155	1,2-Diazoles not condensed and containing further heterocyclic rings
A61K 31/4162	1,2-Diazoles condensed with heterocyclic ring systems
A61K 31/4164	1,3-Diazoles
A61K 31/4166	1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
A61K 31/4168	1,3-Diazoles having a nitrogen atom attached in position 2, e.g. clonidine
A61K 31/4172	Imidazole-alkanecarboxylic acids, e.g. histidine
A61K 31/4174	Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
A61K 31/4178	1,3-Diazoles not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
A61K 31/4184	1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
A61K 31/4188	1,3-Diazoles condensed with heterocyclic ring systems, e.g. biotin, sorbinil
A61K 31/4192	1,2,3-Triazoles
A61K 31/4196	1,2,4-Triazoles
A61K 31/4245	Oxadiazoles
A61K 31/4353	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
A61K 31/4355	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
A61K 31/4365	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
A61K 31/4375	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
A61K 31/4402	Non-condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
A61K 31/4406	Non-condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
A61K 31/4409	Non-condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
A61K 31/4412	Non-condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
A61K 31/4415	Pyridoxine, i.e.vitamin B6
A61K 31/4418	Non-condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine
A61K 31/4422	1,4-Dihydropyridines, e.g. nifedipine, nicardipine
A61K 31/4425	Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
A61K 31/4427	Non-condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
A61K 31/4433	Non-condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
A61K 31/4436	Non-condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
A61K 31/4439	Non-condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61K 31/4453	Non-condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
A61K 31/4458	Non-condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
A61K 31/4462	Non-condensed piperidines, e.g. piperocaine only substituted in position 3
A61K 31/4465	Non-condensed piperidines, e.g. piperocaine only substituted in position 4
A61K 31/4468	Non-condensed piperidines, e.g. piperocaine having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl
A61K 31/4515	Non-condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
A61K 31/4523	Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
A61K 31/4525	Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
A61K 31/4535	Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
A61K 31/4545	Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
A61K 31/4704	2-Quinolinones, e.g. carbostyril
A61K 31/4706	4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
A61K 31/4709	Non-condensed quinolines containing further heterocyclic rings
A61K 31/4725	Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
A61K 31/4738	Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
A61K 31/4741	Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
A61K 31/4743	Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
A61K 31/4745	Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines
A61K 31/4747	Quinolines; Isoquinolines spiro-condensed
A61K 31/4748	Quinolines; Isoquinolines forming part of bridged ring systems
A61K 31/4965	Non-condensed pyrazines
A61K 31/4985	Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A61K 31/4995	Pyrazines or piperazines forming part of bridged ring systems
A61K 31/5025	Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
A61K 31/5355	Non-condensed oxazines containing further heterocyclic rings
A61K 31/5365	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
A61K 31/5375	1,4-Oxazines, e.g. morpholine
A61K 31/5377	1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
A61K 31/5383	1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
A61K 31/5386	1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
A61K 31/5395	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
A61K 31/5415	Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
A61K 31/5513	1,4-Benzodiazepines, e.g. diazepam
A61K 31/5517	1,4-Benzodiazepines, e.g. diazepam condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
A61K 31/5575	Eicosanoids, e.g. leukotrienes having a cyclopentane ring, e.g. prostaglandin E2, prostaglandin F2-alpha
A61K 31/5578	Eicosanoids, e.g. leukotrienes having a pentalene ring system, e.g. carbacyclin, iloprost
A61K 31/5585	Eicosanoids, e.g. leukotrienes having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
A61K 31/5685	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone having an oxo group in position 17, e.g. androsterone
A61K 31/6615	Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
A61K 31/7004	Monosaccharides having only carbon, hydrogen and oxygen atoms
A61K 31/7008	Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
A61K 31/7012	Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
A61K 31/7016	Disaccharides, e.g. lactose, lactulose
A61K 31/7024	Esters of saccharides
A61K 31/7028	Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
A61K 31/7032	Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyl-diacylglycerides, lactobionic acid, gangliosides
A61K 31/7034	Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
A61K 31/7036	Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
A61K 31/7042	Compounds having saccharide radicals and heterocyclic rings
A61K 31/7048	Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A61K 31/7052	Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
A61K 31/7056	Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
A61K 31/7064	Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
A61K 31/7068	Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
A61K 31/7072	Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
A61K 31/7076	Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
A61K 31/7084	Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
A61K 31/7088	Compounds having three or more nucleosides or nucleotides
A61K 31/7105	Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
A61K 31/7115	Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
A61K 31/7125	Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
A61K 31/7135	Compounds containing heavy metals
A61K 33/00	Medicinal preparations containing inorganic active ingredients
A61K 33/02	Ammonia; Compounds thereof
A61K 33/04	Sulfur, selenium or tellurium; Compounds thereof
A61K 33/06	Aluminium, calcium or magnesium; Compounds thereof
A61K 33/08	Oxides; Hydroxides
A61K 33/10	Carbonates; Bicarbonates
A61K 33/12	Magnesium silicate
A61K 33/14	Alkali metal chlorides; Alkaline earth metal chlorides
A61K 33/16	Fluorine compounds
A61K 33/18	Iodine; Compounds thereof
A61K 33/20	Elemental chlorine; Inorganic compounds releasing chlorine
A61K 33/22	Boron compounds
A61K 33/24	Heavy metals; Compounds thereof
A61K 33/26	Iron; Compounds thereof
A61K 33/28	Mercury; Compounds thereof
A61K 33/30	Zinc; Compounds thereof
A61K 33/32	Manganese; Compounds thereof
A61K 33/34	Copper; Compounds thereof
A61K 33/36	Arsenic; Compounds thereof
A61K 33/38	Silver; Compounds thereof
A61K 33/40	Peroxides
A61K 33/42	Phosphorus; Compounds thereof
A61K 33/44	Elemental carbon, e.g. charcoal, carbon black
A61K 33/241	Lead; Compounds thereof
A61K 33/242	Gold; Compounds thereof
A61K 33/243	Platinum; Compounds thereof
A61K 33/244	Lanthanides; Compounds thereof
A61K 33/245	Bismuth; Compounds thereof
A61K 35/00	Medicinal preparations containing materials or reaction products thereof with undetermined constitution
A61K 35/02	Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
A61K 35/04	Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
A61K 35/06	Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
A61K 35/08	Mineral waters; Seawater
A61K 35/10	Peat; Amber; Turf; Humus
A61K 35/12	Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
A61K 35/13	Tumour cells, irrespective of tissue of origin
A61K 35/14	Blood; Artificial blood
A61K 35/15	Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
A61K 35/16	Blood plasma; Blood serum
A61K 35/17	Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
A61K 35/18	Erythrocytes
A61K 35/19	Platelets; Megacaryocytes
A61K 35/20	Milk; Whey; Colostrum
A61K 35/22	Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
A61K 35/23	Kidney
A61K 35/24	Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
A61K 35/26	Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
A61K 35/28	Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
A61K 35/30	Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
A61K 35/32	Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
A61K 35/33	Fibroblasts
A61K 35/34	Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
A61K 35/35	Fat tissue; Adipocytes; Stromal cells; Connective tissues
A61K 35/36	Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
A61K 35/37	Digestive system
A61K 35/38	Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
A61K 35/39	Pancreas; Islets of Langerhans
A61K 35/42	Respiratory system, e.g. lungs, bronchi or lung cells
A61K 35/44	Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
A61K 35/48	Reproductive organs
A61K 35/50	Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
A61K 35/51	Umbilical cord; Umbilical cord blood; Umbilical stem cells
A61K 35/52	Sperm; Prostate; Seminal fluid; Leydig cells of testes
A61K 35/54	Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
A61K 35/55	Glands not provided for in groups , e.g. thyroids, parathyroids or pineal glands
A61K 35/56	Materials from animals other than mammals
A61K 35/57	Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K 35/58	Reptiles
A61K 35/60	Fish, e.g. seahorses; Fish eggs
A61K 35/62	Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
A61K 35/63	Arthropods
A61K 35/64	Insects, e.g. bees, wasps or fleas
A61K 35/65	Amphibians, e.g. toads, frogs, salamanders or newts
A61K 35/66	Microorganisms or materials therefrom
A61K 35/68	Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
A61K 35/74	Bacteria
A61K 35/76	Viruses; Subviral particles; Bacteriophages
A61K 35/407	Liver; Hepatocytes
A61K 35/413	Gall bladder; Bile
A61K 35/545	Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
A61K 35/583	Snakes; Lizards, e.g. chameleons
A61K 35/586	Turtles; Tortoises, e.g. terrapins
A61K 35/612	Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
A61K 35/614	Cnidaria, e.g. sea anemones, corals, coral animals or jellyfish
A61K 35/616	Echinodermata, e.g. starfish, sea cucumbers or sea urchins
A61K 35/618	Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
A61K 35/644	Beeswax; Propolis; Royal jelly; Honey
A61K 35/646	Arachnids, e.g. spiders, scorpions, ticks or mites
A61K 35/648	Myriapods, e.g. centipedes or millipedes
A61K 35/655	Aquatic animals other than those covered by groups
A61K 35/741	Probiotics
A61K 35/742	Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
A61K 35/744	Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
A61K 35/745	Bifidobacteria
A61K 35/747	Lactobacilli, e.g. L. acidophilus or L. brevis
A61K 35/748	Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
A61K 35/761	Adenovirus
A61K 35/763	Herpes virus
A61K 35/765	Reovirus; Rotavirus
A61K 35/766	Rhabdovirus, e.g. vesicular stomatitis virus
A61K 35/768	Oncolytic viruses not provided for in groups
A61K 36/00	Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 36/02	Algae
A61K 36/03	Phaeophycota or phaeophyta (brown algae), e.g. Fucus
A61K 36/04	Rhodophycota or rhodophyta (red algae), e.g. Porphyra
A61K 36/05	Chlorophycota or chlorophyta (green algae), e.g. Chlorella
A61K 36/06	Fungi, e.g. yeasts
A61K 36/07	Basidiomycota, e.g. Cryptococcus
A61K 36/09	Lichens
A61K 36/10	Bryophyta (mosses)
A61K 36/11	Pteridophyta or Filicophyta (ferns)
A61K 36/12	Filicopsida or Pteridopsida
A61K 36/13	Coniferophyta (gymnosperms)
A61K 36/14	Cupressaceae (Cypress family), e.g. juniper or cypress
A61K 36/15	Pinaceae (Pine family), e.g. pine or cedar
A61K 36/16	Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
A61K 36/17	Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
A61K 36/18	Magnoliophyta (angiosperms)
A61K 36/19	Acanthaceae (Acanthus family)
A61K 36/20	Aceraceae (Maple family)
A61K 36/21	Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
A61K 36/22	Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
A61K 36/23	Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
A61K 36/24	Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
A61K 36/25	Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
A61K 36/26	Aristolochiaceae (Birthwort family), e.g. heartleaf
A61K 36/27	Asclepiadaceae (Milkweed family), e.g. hoya
A61K 36/28	Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
A61K 36/29	Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
A61K 36/30	Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
A61K 36/31	Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
A61K 36/32	Burseraceae (Frankincense family)
A61K 36/33	Cactaceae (Cactus family), e.g. pricklypear or Cereus
A61K 36/34	Campanulaceae (Bellflower family)
A61K 36/35	Caprifoliaceae (Honeysuckle family)
A61K 36/36	Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
A61K 36/37	Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
A61K 36/38	Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
A61K 36/39	Convolvulaceae (Morning-glory family), e.g. bindweed
A61K 36/40	Cornaceae (Dogwood family)
A61K 36/41	Crassulaceae (Stonecrop family)
A61K 36/42	Cucurbitaceae (Cucumber family)
A61K 36/43	Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
A61K 36/44	Ebenaceae (Ebony family), e.g. persimmon
A61K 36/45	Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
A61K 36/46	Eucommiaceae (Eucommia family), e.g. hardy rubber tree
A61K 36/47	Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
A61K 36/48	Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
A61K 36/49	Fagaceae (Beech family), e.g. oak or chestnut
A61K 36/50	Fumariaceae (Fumitory family), e.g. bleeding heart
A61K 36/51	Gentianaceae (Gentian family)
A61K 36/52	Juglandaceae (Walnut family)
A61K 36/53	Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
A61K 36/54	Lauraceae (Laurel family), e.g. cinnamon or sassafras
A61K 36/55	Linaceae (Flax family), e.g. Linum
A61K 36/56	Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
A61K 36/57	Magnoliaceae (Magnolia family)
A61K 36/58	Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
A61K 36/59	Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
A61K 36/60	Moraceae (Mulberry family), e.g. breadfruit or fig
A61K 36/61	Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
A61K 36/062	Ascomycota
A61K 36/63	Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
A61K 36/064	Saccharomycetales, e.g. baker's yeast
A61K 36/65	Paeoniaceae (Peony family), e.g. Chinese peony
A61K 36/066	Clavicipitaceae
A61K 36/67	Piperaceae (Pepper family), e.g. Jamaican pepper or kava
A61K 36/068	Cordyceps
A61K 36/69	Polygalaceae (Milkwort family)
A61K 36/70	Polygonaceae (Buckwheat family), e.g. spineflower or dock
A61K 36/71	Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
A61K 36/72	Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
A61K 36/73	Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
A61K 36/074	Ganoderma
A61K 36/75	Rutaceae (Rue family)
A61K 36/076	Poria
A61K 36/77	Sapindaceae (Soapberry family), e.g. lychee or soapberry
A61K 36/78	Saururaceae (Lizard's-tail family)
A61K 36/79	Schisandraceae (Schisandra family)
A61K 36/80	Scrophulariaceae (Figwort family)
A61K 36/81	Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
A61K 36/82	Theaceae (Tea family), e.g. camellia
A61K 36/83	Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
A61K 36/84	Valerianaceae (Valerian family), e.g. valerian
A61K 36/85	Verbenaceae (Verbena family)
A61K 36/86	Violaceae (Violet family)
A61K 36/87	Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
A61K 36/88	Liliopsida (monocotyledons)
A61K 36/89	Cyperaceae (Sedge family)
A61K 36/90	Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
A61K 36/126	Drynaria
A61K 36/185	Magnoliopsida (dicotyledons)
A61K 36/195	Strobilanthes
A61K 36/232	Angelica
A61K 36/233	Bupleurum
A61K 36/234	Cnidium (snowparsley)
A61K 36/235	Foeniculum (fennel)
A61K 36/236	Ligusticum (licorice-root)
A61K 36/237	Notopterygium
A61K 36/238	Saposhnikovia
A61K 36/254	Acanthopanax or Eleutherococcus
A61K 36/258	Panax (ginseng)
A61K 36/264	Aristolochia (Dutchman's pipe)
A61K 36/268	Asarum (wild ginger)
A61K 36/282	Artemisia, e.g. wormwood or sagebrush
A61K 36/284	Atractylodes
A61K 36/285	Aucklandia
A61K 36/286	Carthamus (distaff thistle)
A61K 36/287	Chrysanthemum, e.g. daisy
A61K 36/288	Taraxacum (dandelion)
A61K 36/289	Vladimiria
A61K 36/296	Epimedium
A61K 36/315	Isatis, e.g. Dyer's woad
A61K 36/324	Boswellia, e.g. frankincense
A61K 36/328	Commiphora, e.g. mecca myrrh or balm of Gilead
A61K 36/342	Adenophora
A61K 36/344	Codonopsis
A61K 36/346	Platycodon
A61K 36/355	Lonicera (honeysuckle)
A61K 36/424	Gynostemma
A61K 36/428	Trichosanthes
A61K 36/481	Astragalus (milkvetch)
A61K 36/482	Cassia, e.g. golden shower tree
A61K 36/483	Gleditsia (locust)
A61K 36/484	Glycyrrhiza (licorice)
A61K 36/485	Gueldenstaedtia
A61K 36/486	Millettia
A61K 36/487	Psoralea
A61K 36/488	Pueraria (kudzu)
A61K 36/489	Sophora, e.g. necklacepod or mamani
A61K 36/505	Corydalis
A61K 36/515	Gentiana
A61K 36/532	Agastache, e.g. giant hyssop
A61K 36/533	Leonurus (motherwort)
A61K 36/534	Mentha (mint)
A61K 36/535	Perilla (beefsteak plant)
A61K 36/536	Prunella or Brunella (selfheal)
A61K 36/537	Salvia (sage)
A61K 36/538	Schizonepeta
A61K 36/539	Scutellaria (skullcap)
A61K 36/575	Magnolia
A61K 36/605	Morus (mulberry)
A61K 36/634	Forsythia
A61K 36/638	Ligustrum, e.g. Chinese privet
A61K 36/704	Polygonum, e.g. knotweed
A61K 36/708	Rheum (rhubarb)
A61K 36/714	Aconitum (monkshood)
A61K 36/716	Clematis (leather flower)
A61K 36/718	Coptis (goldthread)
A61K 36/725	Ziziphus, e.g. jujube
A61K 36/732	Chaenomeles, e.g. flowering quince
A61K 36/734	Crataegus (hawthorn)
A61K 36/736	Prunus, e.g. plum, cherry, peach, apricot or almond
A61K 36/738	Rosa (rose)
A61K 36/739	Sanguisorba (burnet)
A61K 36/744	Gardenia
A61K 36/746	Morinda
A61K 36/748	Oldenlandia or Hedyotis
A61K 36/752	Citrus, e.g. lime, orange or lemon
A61K 36/754	Evodia
A61K 36/756	Phellodendron, e.g. corktree
A61K 36/758	Zanthoxylum, e.g. pricklyash
A61K 36/804	Rehmannia
A61K 36/808	Scrophularia (figwort)
A61K 36/815	Lycium (desert-thorn)
A61K 36/835	Aquilaria
A61K 36/855	Clerodendrum, e.g. glorybower
A61K 36/882	Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
A61K 36/884	Alismataceae (Water-plantain family)
A61K 36/886	Aloeaceae (Aloe family), e.g. aloe vera
A61K 36/888	Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
A61K 36/889	Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
A61K 36/894	Dioscoreaceae (Yam family)
A61K 36/896	Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
A61K 36/898	Orchidaceae (Orchid family)
A61K 36/899	Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
A61K 36/902	Sparganiaceae (Bur-reed family)
A61K 36/904	Stemonaceae (Stemona family), e.g. croomia
A61K 36/906	Zingiberaceae (Ginger family)
A61K 36/8884	Arisaema, e.g. Jack in the pulpit
A61K 36/8888	Pinellia
A61K 36/8895	Calamus, e.g. rattan
A61K 36/8905	Cyperus (flatsedge)
A61K 36/8945	Dioscorea, e.g. yam, Chinese yam or water yam
A61K 36/8962	Allium, e.g. garden onion, leek, garlic or chives
A61K 36/8964	Anemarrhena
A61K 36/8965	Asparagus, e.g. garden asparagus or asparagus fern
A61K 36/8966	Fritillaria, e.g. checker lily or mission bells
A61K 36/8967	Lilium, e.g. tiger lily or Easter lily
A61K 36/8968	Ophiopogon (Lilyturf)
A61K 36/8969	Polygonatum (Solomon's seal)
A61K 36/8984	Dendrobium
A61K 36/8988	Gastrodia
A61K 36/8994	Coix (Job's tears)
A61K 36/8998	Hordeum (barley)
A61K 36/9062	Alpinia, e.g. red ginger or galangal
A61K 36/9064	Amomum, e.g. round cardamom
A61K 36/9066	Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
A61K 36/9068	Zingiber, e.g. garden ginger
A61K 38/00	Medicinal preparations containing peptides
A61K 38/01	Hydrolysed proteins; Derivatives thereof
A61K 38/02	Peptides of undefined number of amino acids; Derivatives thereof
A61K 38/03	Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
A61K 38/04	Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
A61K 38/05	Dipeptides
A61K 38/06	Tripeptides
A61K 38/07	Tetrapeptides
A61K 38/08	Peptides having 5 to 11 amino acids
A61K 38/09	Luteinising hormone-releasing hormone [LHRH]; Related peptides
A61K 38/10	Peptides having 12 to 20 amino acids
A61K 38/11	Oxytocins; Vasopressins; Related peptides
A61K 38/12	Cyclic peptides
A61K 38/13	Cyclosporins
A61K 38/14	Peptides containing saccharide radicals; Derivatives thereof
A61K 38/15	Depsipeptides; Derivatives thereof
A61K 38/16	Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A61K 38/17	Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from humans
A61K 38/18	Growth factors; Growth regulators
A61K 38/19	Cytokines; Lymphokines; Interferons
A61K 38/20	Interleukins
A61K 38/21	Interferons
A61K 38/22	Hormones
A61K 38/23	Calcitonins
A61K 38/24	Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
A61K 38/25	Growth hormone-releasing factor [GH-RF] (Somatoliberin)
A61K 38/26	Glucagons
A61K 38/27	Growth hormone [GH] (Somatotropin)
A61K 38/28	Insulins
A61K 38/29	Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
A61K 38/30	Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
A61K 38/31	Somatostatins
A61K 38/32	Thymopoietins
A61K 38/33	Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
A61K 38/34	Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
A61K 38/35	Corticotropin [ACTH]
A61K 38/36	Blood coagulation or fibrinolysis factors
A61K 38/37	Factors VIII
A61K 38/38	Albumins
A61K 38/39	Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
A61K 38/40	Transferrins, e.g. lactoferrins, ovotransferrins
A61K 38/41	Porphyrin- or corrin-ring-containing peptides
A61K 38/42	Haemoglobins; Myoglobins
A61K 38/43	Enzymes; Proenzymes; Derivatives thereof
A61K 38/44	Oxidoreductases (1)
A61K 38/45	Transferases (2)
A61K 38/46	Hydrolases (3)
A61K 38/47	Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
A61K 38/48	Hydrolases (3) acting on peptide bonds (3.4)
A61K 38/49	Urokinase; Tissue plasminogen activator
A61K 38/50	Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
A61K 38/51	Lyases (4)
A61K 38/52	Isomerases (5)
A61K 38/53	Ligases (6)
A61K 38/54	Mixtures of enzymes or proenzymes covered by more than a single one of groups or
A61K 38/55	Protease inhibitors
A61K 38/56	Protease inhibitors from plants
A61K 38/57	Protease inhibitors from humans
A61K 38/58	Protease inhibitors from humans from leeches, e.g. hirudin, eglin
A61K 38/095	Oxytocins; Vasopressins; Related peptides
A61K 39/00	Medicinal preparations containing antigens or antibodies
A61K 39/002	Protozoa antigens
A61K 39/04	Mycobacterium, e.g. Mycobacterium tuberculosis
A61K 39/005	Trypanosoma antigens
A61K 39/07	Bacillus
A61K 39/08	Clostridium, e.g. Clostridium tetani
A61K 39/09	Streptococcus
A61K 39/10	Brucella; Bordetella, e.g. Bordetella pertussis
A61K 39/12	Viral antigens
A61K 39/13	Poliovirus
A61K 39/15	Reoviridae, e.g. calf diarrhea virus
A61K 39/17	Newcastle disease virus
A61K 39/018	Babesia antigens, e.g. Theileria antigens
A61K 39/20	Rubella virus
A61K 39/21	Retroviridae, e.g. equine infectious anemia virus
A61K 39/23	Parvoviridae, e.g. feline panleukopenia virus
A61K 39/25	Varicella-zoster virus
A61K 39/27	Equine rhinopneumonitis virus
A61K 39/29	Hepatitis virus
A61K 39/35	Allergens
A61K 39/36	Allergens from pollen
A61K 39/38	Antigens from snakes
A61K 39/39	Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
A61K 39/40	Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
A61K 39/42	Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
A61K 39/44	Antibodies bound to carriers
A61K 39/085	Staphylococcus
A61K 39/095	Neisseria
A61K 39/102	Pasteurella; Haemophilus
A61K 39/104	Pseudomonas
A61K 39/106	Vibrio; Campylobacter
A61K 39/108	Escherichia; Klebsiella
A61K 39/112	Salmonella; Shigella
A61K 39/114	Fusobacterium
A61K 39/116	Polyvalent bacterial antigens
A61K 39/118	Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
A61K 39/125	Picornaviridae, e.g. calicivirus
A61K 39/135	Foot-and-mouth disease virus
A61K 39/145	Orthomyxoviridae, e.g. influenza virus
A61K 39/155	Paramyxoviridae, e.g. parainfluenza virus
A61K 39/165	Mumps or measles virus
A61K 39/175	Canine distemper virus
A61K 39/187	Hog cholera virus
A61K 39/193	Equine encephalomyelitis virus
A61K 39/205	Rhabdoviridae, e.g. rabies virus
A61K 39/215	Coronaviridae, e.g. avian infectious bronchitis virus
A61K 39/225	Porcine transmissible gastroenteritis virus
A61K 39/235	Adenoviridae
A61K 39/245	Herpetoviridae, e.g. herpes simplex virus
A61K 39/255	Marek's disease virus
A61K 39/265	Infectious rhinotracheitis virus
A61K 39/275	Poxviridae, e.g. avipoxvirus
A61K 39/285	Vaccinia virus or variola virus
A61K 39/295	Polyvalent viral antigens; Mixtures of viral and bacterial antigens
A61K 39/385	Haptens or antigens, bound to carriers
A61K 39/395	Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A61K 41/00	Medicinal preparations obtained by treating materials with wave energy or particle radiation
A61K 41/10	Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
A61K 41/13	Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultrasonic waves
A61K 41/17	Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
A61K 45/00	Medicinal preparations containing active ingredients not provided for in groups
A61K 45/06	Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61K 45/08	Mixtures of an active ingredient and an auxiliary substance neither being chemically characterised, e.g. antihistaminicum and surface active substance
A61K 47/00	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K 47/02	Inorganic compounds
A61K 47/04	Non-metals; Compounds thereof
A61K 47/06	Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
A61K 47/08	Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen
A61K 47/10	Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
A61K 47/12	Carboxylic acids; Salts or anhydrides thereof
A61K 47/14	Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/16	Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen
A61K 47/18	Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
A61K 47/20	Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
A61K 47/22	Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K 47/24	Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
A61K 47/26	Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 47/28	Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
A61K 47/30	Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
A61K 47/32	Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers
A61K 47/34	Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 47/36	Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
A61K 47/38	Cellulose; Derivatives thereof
A61K 47/40	Cyclodextrins; Derivatives thereof
A61K 47/42	Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
A61K 47/44	Oils, fats or waxes according to two or more groups of ; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
A61K 47/46	Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
A61K 47/48	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
A61K 47/50	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
A61K 47/51	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
A61K 47/52	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
A61K 47/54	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
A61K 47/55	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
A61K 47/56	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
A61K 47/58	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
A61K 47/59	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
A61K 47/60	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
A61K 47/61	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
A61K 47/62	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
A61K 47/64	Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
A61K 47/65	Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
A61K 47/66	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
A61K 47/68	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
A61K 47/69	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
A61K 48/00	Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
A61K 49/00	Preparations for testing in vivo
A61K 49/04	X-ray contrast preparations
A61K 49/06	Nuclear magnetic resonance (NMR) contrast preparations; Magnetic resonance imaging (MRI) contrast preparations
A61K 49/08	Nuclear magnetic resonance (NMR) contrast preparations; Magnetic resonance imaging (MRI) contrast preparations characterised by the carrier
A61K 49/10	Organic compounds
A61K 49/12	Macromolecular compounds
A61K 49/14	Peptides, e.g. proteins
A61K 49/16	Antibodies; Immunoglobulins; Fragments thereof
A61K 49/18	Nuclear magnetic resonance (NMR) contrast preparations; Magnetic resonance imaging (MRI) contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
A61K 49/20	Nuclear magnetic resonance (NMR) contrast preparations; Magnetic resonance imaging (MRI) contrast preparations containing free radicals
A61K 49/22	Echographic preparations; Ultrasound imaging preparations
A61K 50/00	Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ECG) or for transcutaneous drug administration
A61K 51/00	Preparations containing radioactive substances for use in therapy or testing in vivo
A61K 51/02	Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier
A61K 51/04	Organic compounds
A61K 51/06	Macromolecular compounds
A61K 51/08	Peptides, e.g. proteins
A61K 51/10	Antibodies or immunoglobulins; Fragments thereof
A61K 51/12	Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes
A61K 101/00	Radioactive non-metals
A61K 101/02	Halogens
A61K 103/00	Radioactive metals
A61K 103/10	Technetium; Rhenium
A61K 103/20	Indium
A61K 103/30	Rare earths
A61K 103/32	Yttrium
A61K 103/34	Gadolinium
A61K 103/36	Ytterbium
A61K 103/40	Actinides
A61K 125/00	Containing or obtained from roots, bulbs, tubers, corms or rhizomes
A61K 127/00	Containing or obtained from leaves
A61K 129/00	Containing or obtained from bark
A61K 131/00	Containing or obtained from seeds, nuts, fruits or grains
A61K 133/00	Containing or obtained from flowers or blossoms
A61K 135/00	Containing or obtained from stems, stalks, branches, twigs or shoots